Brightsurf Science News & Current Events

March 30, 2008
Rising Australian biotech stars set to connect on the world stage
Two of Australia's leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the country's burgeoning biopharmaceutical industry.

Vaccine for Ebola virus
One of the world's deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian researchers, who have successfully tested several Ebola vaccines in primates and are now looking to adapt them for human use.

Young cancer researcher to meet the world's best
A young Hunter cancer researcher will visit the United States next week to meet with some of the world's leading cancer researchers and establish research alliances for our region.

Communicating your way to a healthy heart
Temple University researchers recently finished a four-year study which found that pairing an interned-based health reporting system with regular clinic visits enabled healthy patients in rural and urban settings at high-risk for heart disease to lower risk factors through frequent communication with their doctor.

High-dose tirofiban as effective as abciximab in reducing ST-segment elevation in STEMI patients
Data from a Phase III, open label, multi-national study of patients undergoing angioplasty for ST-elevation myocardial infarction, showed that treatment with tirofiban led to non-inferior ST-segment resolution compared to abciximab.

Chips could speed up detection of livestock viruses
Some of the worst threats to farm workers and farm animals such as bird flu, foot-and-mouth disease and other emerging viruses could soon be quickly identified by using a simple screening chip developed by scientists from the Institute for Animal Health, scientists will hear today (Monday, March 31, 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Center.

Major international collaboration offers new clues to genetics of type 2 diabetes
An international collaboration of scientists from Europe and the US has identified six new genes which play a role in the development of type 2 diabetes, extending the total number of genes implicated in common forms of the disease to 16.

Most people believe smallpox not an extinct disease
The vast majority of Scottish people interviewed in the streets of Edinburgh are unaware of one of the greatest achievements of medical science -- the eradication of smallpox from the world over 40 years ago.

Experts from Penn's School of Medicine to present at ACC Annual Scientific Session
Penn experts will present research findings that could come to define new standards of cardiovascular diagnostics and care at this weekend's conference of the American College of Cardiology, the foremost professional society representing heart specialists throughout the world.

Potential association of type 2 diabetes genes with prostate cancer
Scientists have identified six new genes which play a role in the development of type 2 diabetes, and among the group is the second gene known to also play a role in prostate cancer.

Green tea helps beat superbugs
Green tea can help beat superbugs according to Egyptian scientists speaking March 31, 2008 at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

Major collaboration uncovers surprising new genetic clues to diabetes
An international team that included scientists from the National Human Genome Research Institute, part of the National Institutes of Health, today reported it has identified six more genetic variants involved in type 2 diabetes, boosting to 16 the total number of genetic risk factors associated with increased risk of the disease.

No laughing matter -- bacteria are releasing a serious greenhouse gas
Unlike carbon dioxide and methane, laughing gas has been largely ignored by world leaders as a worrying greenhouse gas.

Comparison of anticoagulants for angioplasty show similar outcomes
In a comparison of anticoagulants and stents for use with angioplasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardiac measures within 90 minutes after the procedure, while patients who received stents that released the drug sirolimus had a lower risk of major adverse cardiac events within 8 months than patients who received uncoated stents, according to a JAMA study being released early online March 30.

DendriMed scientist seeks to fast-track success
Gleaning critical technical knowledge and building important international relationships is top of the agenda for rising Australian biotechnology star, DendriMed Research Director Dr.

Neurons hard wired to tell left from right
It's well-known that the left and right sides of the brain differ in many animal species and this is thought to influence cognitive performance and social behaviour.

Team explains 'the wallpaper problem'
Frustrated by tape that won't peel off the roll in a straight line?

MRSA in hospital intensive care -- what's growing where?
Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today (Monday, March 31, 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Center.

3-D imaging -- first insights into magnetic fields
Researchers from the Hahn-Meitner-Institute in Berlin in cooperation with University of Applied Sciences in Berlin have succeeded, for the first time, in a direct, 3-D visualization of magnetic fields inside solid, non-transparent materials.

Antisense therapeutics scientist out to pull more big deals
Aiming for more major licensing deals like the one his company recently secured with top 20 global pharmaceutical company, Teva, is front of mind for rising Australian biotechnology star, Antisense Therapeutics Ltd.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.